₩3,600,000 – ₩6,600,000
루마니아의 암 치료제 시장은 암 발병 건수 증가와 치료법의 지속적인 발전 덕분에 꾸준히 성장하고 있습니다. 암은 여전히 루마니아에서 주요 사망 원인 중 하나이며, 루마니아 보건부는 매년 약 10만 건의 새로운 암 진단 사례가 발생한다고 보고하고 있습니다. 흡연, 불균형한 식습관, 고령화와 같은 위험 요인의 증가는 암 발병률을 높이고 있으며, 이에 따라 표적 치료, 면역 치료, 정밀 의학을 포함한 혁신적인 치료법에 대한 수요가 증가하고 있습니다.
그러나 특히 의료 인프라가 미비한 농촌 지역에서는 첨단 암 치료에 대한 접근성이 여전히 어려운 과제입니다. 이러한 제약에도 불구하고, 루마니아의 의료 시스템 강화와 현대적인 암 치료 접근성 확대를 목표로 하는 국가적 차원의 정책과 유럽 연합의 지원에 힘입어 향후 시장은 더욱 확대될 것으로 예상됩니다.
Romania's cancer therapeutics market is experiencing consistent growth, fueled by a rising number of cancer cases and ongoing advancements in treatment methods. Cancer remains one of the leading causes of mortality in the country, with the Romanian Ministry of Health reporting approximately 100,000 new diagnoses each year. The increasing prevalence of risk factors such as tobacco use, unhealthy diets, and an aging population continues to drive cancer incidence rates, thereby increasing the need for innovative treatment approaches, including targeted therapies, immunotherapies, and precision medicine.
Nonetheless, access to advanced cancer care remains a challenge, particularly in rural regions where healthcare infrastructure is often underdeveloped. Despite these limitations, the market is expected to expand in the years ahead, supported by national initiatives and assistance from the European Union aimed at strengthening Romania’s healthcare system and broadening access to modern cancer treatments.
TABLE OF CONTENTS
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. Romania Cancer Therapeutics Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Cancer Therapeutics Market Key Market Dynamics
5.1 Cancer Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. Romania Cancer Therapeutics Market – Analysis
6.1 Romania Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
6.2 Romania Cancer Therapeutics Market Revenue and Forecast Analysis
7. Romania Cancer Therapeutics Market Analysis – by Therapy Types
7.1 Romania Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
8. Romania Cancer Therapeutics Market Analysis – by Indications
8.1 Romania Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
9. Romania Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Romania Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.1 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.2 Partnerships and Collaborations
11.2 Other Developments
12. Company Profiles
12.1 Bristol-Myers Squibb Co
12.1. 1 Key Facts
12.1. 2 Business Description
12.1. 3 Products and Services
12.1. 4 Financial Overview
12.1. 5 SWOT Analysis
12.1. 6 Key Developments
12.2 AbbVie Inc
12.2. 1 Key Facts
12.2. 2 Business Description
12.2. 3 Products and Services
12.2. 4 Financial Overview
12.2. 5 SWOT Analysis
12.2. 6 Key Developments
12.3 Johnson & Johnson
12.3. 1 Key Facts
12.3. 2 Business Description
12.3. 3 Products and Services
12.3. 4 Financial Overview
12.3. 5 SWOT Analysis
12.3. 6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4. 1 Key Facts
12.4. 2 Business Description
12.4. 3 Products and Services
12.4. 4 Financial Overview
12.4. 5 SWOT Analysis
12.4. 6 Key Developments
12.5 Pfizer Inc
12.5. 1 Key Facts
12.5. 2 Business Description
12.5. 3 Products and Services
12.5. 4 Financial Overview
12.5. 5 SWOT Analysis
12.5. 6 Key Developments
12.6 AstraZeneca Plc
12.6. 1 Key Facts
12.6. 2 Business Description
12.6. 3 Products and Services
12.6. 4 Financial Overview
12.6. 5 SWOT Analysis
12.6. 6 Key Developments
12.7 Merck KGaA
12.7. 1 Key Facts
12.7. 2 Business Description
12.7. 3 Products and Services
12.7. 4 Financial Overview
12.7. 5 SWOT Analysis
12.7. 6 Key Developments
12.8 Novartis AG
12.8. 1 Key Facts
12.8. 2 Business Description
12.8. 3 Products and Services
12.8. 4 Financial Overview
12.8. 5 SWOT Analysis
12.8. 6 Key Developments
12.9 Astellas Pharma Inc
12.9. 1 Key Facts
12.9. 2 Business Description
12.9. 3 Products and Services
12.9. 4 Financial Overview
12.9. 5 SWOT Analysis
12.9. 6 Key Developments
12.10 Eli Lilly and Co
12.10. 1 Key Facts
12.10. 2 Business Description
12.10. 3 Products and Services
12.10. 4 Financial Overview
12.10. 5 SWOT Analysis
12.10. 6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
TABLE OF TABLES
Table 1. Romania Cancer Therapeutics Market Segmentation
Table 2. List of Vendors
Table 3. Romania Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
Table 4. Romania Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. Romania Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
Table 6. Romania Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
Table 7. Romania Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 8. Romania Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 9. Romania Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
Table 10. Romania Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
Table 11. List of Abbreviations
TABLE OF FIGURES
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. Romania Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
Figure 3. Heat Map Analysis by Key Players
Figure 4. Company Positioning and Concentration